MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA

被引:99
|
作者
Wang, Yihui [1 ]
Tang, Qingchao [2 ]
Li, Mingqi [1 ]
Jiang, Shixiong [1 ]
Wang, Xishan [2 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 3, Dept Colorectal Surg, Harbin 150081, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 2, Ctr Canc, Harbin 150086, Peoples R China
关键词
miR-375; Colorectal cancer; PIK3CA; PI3K; Akt; PI3K-AKT PATHWAY; DOWN-REGULATION; GASTRIC-CANCER; MIR-375; PROTEIN; CELLS; PROGRESSION; EXPRESSION; NEOPLASIA; CARCINOMA;
D O I
10.1016/j.bbrc.2014.01.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Colorectal cancer (CRC) is the second most common cause of death from cancer. MicroRNAs (miRNAs) represent a class of small non-coding RNAs that control gene expression by triggering RNA degradation or interfering with translation. Aberrant miRNA expression is involved in human disease including cancer. Herein, we showed that miR-375 was frequently down-regulated in human colorectal cancer cell lines and tissues when compared to normal human colon tissues. PIK3CA was identified as a potential miR-375 target by bioinformatics. Overexpression of miR-375 in SW480 and HCT15 cells reduced PIIGCA protein expression. Subsequently, using reporter constructs, we showed that the PIK3CA untranslated region (3'-UTR) carries the directly binding site of miR-375. Additionally, miR-375 suppressed CRC cell proliferation and colony formation and led to cell cycle arrest. Furthermore, miR-375 overexpression resulted in inhibition of phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway. SiRNA-mediated silencing of PIK3CA blocked the inhibitory effect of miR-375 on CRC cell growth. Lastly, we found overexpressed miR-375 effectively repressed tumor growth in xenograft animal experiments. Taken together, we propose that overexpression of miR-375 may provide a selective growth inhibition for CRC cells by targeting PI3K/Akt signaling pathway. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 50 条
  • [1] MicroRNA-375 functions as a tumor suppressor in osteosarcoma by targeting PIK3CA
    Shi, Zhi-cai
    Chu, Xue-rong
    Wu, Yun-gang
    Wu, Jin-hui
    Lu, Chun-wen
    Lu, Run-xiao
    Ding, Mu-chen
    Mao, Ning-fang
    TUMOR BIOLOGY, 2015, 36 (11) : 8579 - 8584
  • [2] MicroRNA-375 suppresses human colorectal cancer metastasis by targeting Frizzled 8
    Xu, Lingling
    Wen, Tao
    Liu, Zhe
    Xu, Feng
    Yang, Lei
    Liu, Jian
    Feng, Guosheng
    An, Guangyu
    ONCOTARGET, 2016, 7 (26) : 40644 - 40656
  • [3] PIK3CA in colorectal cancer
    Cathomas, Gieri
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [4] RNAi knockdown of PIK3CA preferentially inhibits invasion of mutant PIK3CA cells
    Zhou, Xin-Ke
    Tang, Sheng-Song
    Yi, Gao
    Hou, Min
    Chen, Jin-Hui
    Yang, Bo
    Liu, Ji-Fang
    He, Zhi-Min
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (32) : 3700 - 3708
  • [5] Expression levels of microRNA-375 in colorectal carcinoma
    Dai, Xiaoning
    Chiang, Yeunpo
    Wang, Zhenning
    Song, Yongxi
    Lu, Chong
    Gao, Peng
    Xu, Huimian
    MOLECULAR MEDICINE REPORTS, 2012, 5 (05) : 1299 - 1304
  • [6] Reciprocal regulation of Daxx and PIK3CA promotes colorectal cancer cell growth
    Huang, Yen-Sung
    Wu, Chang-Chieh
    Chang, Che-Chang
    Huang, Shiu-Feng
    Kuo, Hong-Yi
    Shih, Hsiu-Ming
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (07)
  • [8] Up-regulation of microRNA-375 inhibits the proliferation of gastric cancer cell through targeting AEG-1.
    Cai, Zhihui
    Tan, Shiyun
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (15): : 6556 - 6560
  • [9] The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer
    Xu, Lingling
    Li, Minzhe
    Wang, Min
    Yan, Dong
    Feng, Guosheng
    An, Guangyu
    BMC CANCER, 2014, 14
  • [10] PIK3CA mutation and methylation influences the outcome of colorectal cancer
    Iida, Satoru
    Kato, Shunsuke
    Ishiguro, Megumi
    Matsuyama, Takatoshi
    Ishikawa, Toshiaki
    Kobayashi, Hirotoshi
    Higuchi, Tetsuro
    Uetake, Hiroyuki
    Enomoto, Masayuki
    Sugihara, Kenichi
    ONCOLOGY LETTERS, 2012, 3 (03) : 565 - 570